Claude Bagnis

1.9k citations
52 papers · 1.5k indexed · h-index 21
Topics
Virus-based gene therapy research (29 papers)RNA Interference and Gene Delivery (14 papers)CRISPR and Genetic Engineering (9 papers)
Partner nations
FranceBelgiumItaly

In The Last Decade

Claude Bagnis

51 papers receiving 1.5k citations

Peers

Claude Bagnis
Comparison fields: 5 of 99
  • Molecular Biology 822
  • Immunology 344
  • Genetics 318
  • Genetics 317
  • Surgery 283
Replace Dean H. Betts with:
Dean H. Betts Canada
Ken-ichiro Kosai Japan
Annelii Ny Belgium
M. Carrie Miceli United States
Jean Michel Heard France
Si‐Tse Jiang Taiwan
Roni Mamluk United States
Catherine E. Hughes United Kingdom
William B. Solomon United States
Rosa M. Marión Spain
Claude Bagnis relative to Dean H. Betts Canada Dean H. Betts's profile →
Citations per field
00.5×1.5×2.0×
Dean H. Betts · 1×
Citations per year

Countries citing papers authored by Claude Bagnis

Since Specialization
Citations

This map shows the geographic impact of Claude Bagnis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Bagnis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Bagnis more than expected).

Fields of papers citing papers by Claude Bagnis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Bagnis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Bagnis. The network helps show where Claude Bagnis may publish in the future.

Co-authorship network of co-authors of Claude Bagnis

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Bagnis. A scholar is included among the top collaborators of Claude Bagnis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Bagnis. Claude Bagnis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 10
3 27
4 13
5 20
6 97
7 24
8 90
9 7
10 321
11 12
12 19
13 22
14 33
15 27
16 42
17 66
18 11
19 9
20 22

About Claude Bagnis

Claude Bagnis is a scholar working on Genetics, Biotechnology and Immunology, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (29 papers), RNA Interference and Gene Delivery (14 papers) and CRISPR and Genetic Engineering (9 papers). The work is most often cited by research in Genetics (318 citations), Immunology (344 citations) and Molecular Biology (822 citations). Claude Bagnis has collaborated with scholars based in France, Belgium and Italy. Frequent co-authors include P Mannoni, Christian Dani, Brigitte Wdziekonski, Claude A. Dechesne, Didier F. Pisani, Jean‐Yves Kurzenne, Albert Villageois, Jean‐Philippe Breittmayer, Gérard Ailhaud and Claude Turc‐Carel. Their work appears in journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026